Melanoma (stage III or IV) - ipilimumab: Bristol Myers-Squibb (PAS Submission)
Melanoma (stage III or IV) - ipilimumab: Bristol Myers-Squibb (PAS Submission)
02 November 2012 (487.99 Kb 22 sec) |
This page was last updated: 31 October 2012